TERT-BUTYL 4-(2,6-DICHLOROPYRIMIDIN-4-YL)PIPERAZINE-1-CARBOXYLATE, 95%, 100mg

(R)-2-Amino-2-methyl-3-(tritylthio)propanoic acid, 97%, 250mg

(2R,5R)-tert-Butyl 5-(hydroxymethyl)-2-methylpiperazine-1-carboxylate, 95.0%, 1g

2-ETHOXY-5-FLUOROISONICOTINIC ACID, 95.0%, 5g

(R)-3-(1-aminoethyl)-5-(trifluoromethyl)aniline hydrochloride, 98%, 1g

5-Chloro-2-methylbenzonitrile>98.0%(GC)1g

3,4-Dihydroxy-6-nitrobenzaldehyde, 95.0%, 1g

1-Benzo[B]thiophen-3-yl-2-bromoethan-1-one, 95.0%, 1g

4-Methyl-2-pyrrolidinone, 95.0%, 250mg

Tubes à essai avec bord, Matériau cylindrique, PP, 2000 Pièce(s)

1,2,2,3-Propanetetracarbonitrile>96.0%(GC)1g

Fmoc-9-Amino-4,7-dioxanonanoic acid, 98.0%, 25g

(S)-3-([1,1'-Biphenyl]-3-yl)-2-((tert-butoxycarbonyl)amino)propanoic acid, 95%, 250mg